Handling both transactional and regulatory mandates, Goldfarb Gross Seligman & Co. acts for pharmaceutical, medical device, digital health and AI health companies, as well as start-ups, academic technology transfer offices, and research centres. Practice head Hili Cohen routinely advises technology-based life sciences and healthcare companies on day-to-day issues, corporate law, fund raising, strategic partnerships, and M&A, while Danny Kleinhendler acts for healthcare and life sciences clients on cross-border transactions, financings and licensing. The team also features experienced practitioners Shir Shalev and Ofir Goldstein.
Legal 500 Editorial commentary
Key clients
- 3 Millenium Group
- Abbott Laboratories
- Accelmed
- Acthera Therapeutics
- Agada Medical
- AISAP
- AIVF
- Align Technology
- Almeda Ventures
- American Well
- AMG American Medical Genetics
- AquafitIntimate
Work highlights
Advising medical device company Magenta Medical on its $105m Series E financing round.
Advising the Special Committee of the Board of Directors of Taro Pharmaceutical Industries on its $671m going private transaction by merger with its controlling shareholder, SUN PHARMA Pharmaceutical Industries.
Advising Israeli biomed company CartiHeal on its acquisition by international medical device company Smith+Nephew for up to $330m.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Hili Cohen
Other key lawyers
Danny Kleinhendler; Shir Shalev; Ofir Goldstein